Thomas Herz
Impact in
-
- Cancer Immunotherapy and Biomarkers
-
- Synthesis and biological activity
- Synthesis and Characterization of Heterocyclic Compounds
- Quinazolinone synthesis and applications
Papers in
-
- Chemical Synthesis and Analysis 2
- Oncology 3
- Colorectal Cancer Treatments and Studies 1
- Cancer Treatment and Pharmacology 1
- Co-authors
- Bernd Krämer (2 shared papers)Tobias Wiestler (1 shared paper)Marie‐Caroline Dieu‐Nosjean (1 shared paper)Moritz Widmaier (1 shared paper)Christoph Schächtele (2 shared papers)Tze Heng Tan (1 shared paper)Markus H. J. Seifert (1 shared paper)Hélène Kaplon (1 shared paper)
- Journals
- International Journal of Quantum Chemistry (2 papers)Journal of the American Chemical Society (1 paper)Expert Opinion on Drug Metabolism & Toxicology (1 paper)Bioorganic & Medicinal Chemistry (1 paper)Journal of Clinical Oncology (1 paper)
- Partner nations
- GermanyUnited StatesCzechia
In The Last Decade
Thomas Herz
11 papers receiving 226 citations
Peers
Comparison fields: 5 of 52
- Oncology 86
- Organic Chemistry 53
- Immunology 39
- Cancer Research 23
- Health Informatics 2
Countries citing papers authored by Thomas Herz
This map shows the geographic impact of Thomas Herz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Herz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Herz more than expected).
Fields of papers citing papers by Thomas Herz
This network shows the impact of papers produced by Thomas Herz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Herz. The network helps show where Thomas Herz may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Herz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 77 | |
| 2 | 2013 | 39 | |
| 3 | 2009 | 34 | |
| 4 | 2009 | 22 | |
| 5 | 2004 | 20 | |
| 6 | 2018 | 20 | |
| 7 | 1999 | 8 | |
| 8 | 2006 | 7 | |
| 9 | 2013 | 7 | |
| 10 | 2000 | 1 | |
| 11 | 2001 | 1 |
About Thomas Herz
Thomas Herz is a scholar working on Molecular Biology, Oncology, Organic Chemistry, Atomic and Molecular Physics, and Optics and Computational Theory and Mathematics, having authored 11 papers that have together received 236 indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (2 papers), Chemical Synthesis and Analysis (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (1 paper), Colorectal Cancer Treatments and Studies (1 paper), Cancer Treatment and Pharmacology (1 paper), Quinazolinone synthesis and applications (1 paper), Advanced Chemical Physics Studies (1 paper) and Photochemistry and Electron Transfer Studies (1 paper). The work is most often cited by research in Oncology (86 citations), Organic Chemistry (53 citations), Immunology (39 citations), Cancer Research (23 citations) and Health Informatics (2 citations). Thomas Herz has collaborated with scholars based in Germany, United States and Czechia. Frequent co-authors include Bernd Krämer, Tobias Wiestler, Marie‐Caroline Dieu‐Nosjean, Moritz Widmaier, Christoph Schächtele, Tze Heng Tan, Markus H. J. Seifert, Hélène Kaplon, Rolf Krauss and Diane Damotte. Their work appears in journals such as International Journal of Quantum Chemistry, Journal of the American Chemical Society, Expert Opinion on Drug Metabolism & Toxicology, Bioorganic & Medicinal Chemistry and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.